Windtree Therapeutics Secures Global Patent Filings for Istaroxime
WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) has announced the completion of national phase filings for its istaroxime patent applications across key global markets, including the United States, Germany, …
Windtree Therapeutics Secures Global Patent Filings for Istaroxime Read More